Iodine-123 BMIPP Scintigraphy in the Evaluation of Patients with Heart Failure

References

• Beer M., Seyfarth T., Sandstede J., Landschütz W., Lipke C., Köstler H., et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002; 40: 1267–74
   PubMed Web of Science ®Google Scholar
• Chen S. L., Uehara T., Morozumi T., Yamagami H., Kusuoka H., Nishimura T. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cadiomyopathy: Assessment by radial long-axis SPET. Nucl Med Commun 1995; 16: 336–43
   Google Scholar
• Fujibayashi Y., Yonekura Y., Takemura Y., Wada K., Matsumoto K., Tamaki N., et al. Myocardial accumulation of iodinated betamethyl-branched fatty acid analogue, iodine-123-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818–22
   Google Scholar
• Hock A., Freundlieb C., Vyska K., Losse B., Erbel R., Feinendegen L. E. Myocardial imaging and metabolic studies with [17-123I] iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy. J Nucl Med 1983; 24: 22–8
   PubMedGoogle Scholar
• Ishida Y., Yasumura Y., Nagata N., Fukuchi K., Komamura K., Takamiya M., et al. Myocardial imaging with 123I-BMIPP in patients with congestive heart failure. Int J Cardiac Imag 1999; 15: 71–7
   Google Scholar
• Kates A. M., Herrero P., Dence C., Soto P., Srinivasan M., Delano D. G., et al. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol 2003; 41: 293–9
   Web of Science ®Google Scholar
• Knapp F. F., Jr., Kropp J. BMIPP design and development. Int J Cardiac Imag 1999; 15: 1–9
   Google Scholar
• Kronik G., Slany J., Mosslacher H. Comparative value of eight M-mode echocardiographic formulas for determining left ventricular stroke volume. A correlative study with thermodilution and left ventricular single-plane cineangiography. Circulation 1979; 60: 1308–16
   PubMed Web of Science ®Google Scholar
• Lopaschuk G. D. Metabolic abnormalities in the diabetic heart. Heart Fail Rev 2002; 7: 149–59
   PubMedGoogle Scholar
• Matsuo S., Nakamura Y., Takahashi M., Mitsunami K., Kinoshita M. Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia. Jpn Circ J 1998; 62: 167–72
   Google Scholar
• Matsuo S., Takahashi M., Nakamura Y., Kinoshita M. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia. J Nucl Med 1996; 37: 712–7
   Google Scholar
• Neubauer S., Horn M., Cramer M., Harre K., Newell J. B., Peters W., et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190–6
   PubMed Web of Science ®Google Scholar
• Nishimura T. Beta-methl-p-(123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy. Int J Cardiac Imag 1999; 15: 41–8
   Google Scholar
• Nohara R., Hosokawa R., Hirai T., Okuda K., Ogino M., Fujibayashi Y., et al. Basic kinetics of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium. Int J Cardiac Imag 1999; 15: 11–20
   Google Scholar
• Nohara R., Okuda K., Ogino M., Hosokawa R., Tamaki N., Konishi J., et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996; 37: 1403–7
   Google Scholar
• Ogawa K., Oida A., Sugimura H., Kaneko N., Nogi N., Hasumi M., et al. Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: comparison of electrocardiography, chest radiography and echocardiography. Circ J 2002; 66: 122–6
   PubMed Web of Science ®Google Scholar
• Sakamoto K., Yamasaki Y., Nanto S., Shimonagata T., Morozumi T., Ohara T., et al. Mechanism of impaired left ventricular wall motion in the diabetic heart without coronary artery disease. Diabetes Care 1998; 21: 2123–8
   Google Scholar
• Tadamura E., Kudoh K., Hattori N., Inubushi M., Magata Y., Konishi J., et al. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med 1998; 39: 390–6
   PubMed Web of Science ®Google Scholar
• Tadamura E., Tamaki N., Kudoh T., Hattori N., Konishi J. BMIPP compared with PET metabolism. Int J Cardiac Imag 1999; 15: 61–9
   Google Scholar
• Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509–16
   PubMed Web of Science ®Google Scholar
• Ugolini V., Hansen C. L., Kulkarni P., Jansen D. E., Akers M. S., Corbett J. R. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenyl-pentadecanoic acid tomographic imaging. Am J Cardiol 1988; 62: 923–8
   Google Scholar
• Wieczorek S. J., Wu A. H., Christenson R., Krishnaswamy P., Gottlieb S., Rosano T., et al. A rapid B-type natriuretic assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002; 144: 834–9
   PubMed Web of Science ®Google Scholar
• Yamaguchi S., Takeishi Y., Minamihaba O., Arimoto T., Hirono O., Takahashi H., et al. Angiotensin-converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure. Nucl Med Commun 2003; 24: 901–6
   Google Scholar
• Yamamichi Y., Kusuoka H., Morishita K., Shirakami Y., Kurami M., et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995; 36: 1043–50
   Google Scholar
• Yazaki Y., Isobe M., Takahashi W., Kitabayashi H., Nishiyama O., Sekiguchi M., et al. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course. Heart 1999; 81: 153–9
   PubMed Web of Science ®Google Scholar